MORECOVER

Details for Australian Trade Mark No. 1042347 (hide)

Owner Sanofi

Convention US 21 SEPTEMBER 2004 78/486964

Service Spruson & Ferguson

Various Convention priority claimed: 21 September 2004, United States of America, No. 78/486964 in respect of PHARMACEUTICAL PREPARATIONS FOR HUMAN USE.

Filing Date 16 February 2005

Classes

Class 5 Pharmaceutical preparations for human use, including pharmaceutical preparations for human use for the treatment and prevention of obesity, diabetes, incontinence, cardiovascular diseases, central nervous system diseases and disorders, stroke, cancer, inflammation and inflammatory diseases, respiratory and infectious diseases, auto-immune diseases, solid organ transplant rejection; antibiotics, anti-fungals, anti-virals and immunosuppressants; diagnostic pharmaceutical preparations used to increase heart rate and contrast imaging agents

Event Publications

10 March 2005 Application filed

10 March 2005 Application Accepted

7 July 2005 Trade Mark Registered/Protected

15 May 2008 Subsequent Owners/Holder Registered - Full Assignment

  Bristol-Myers Squibb Company a Delaware corporation is the full asignee of SANOFI-AVENTIS.

12 July 2012 Registrations/Protected IR Name Amendment and Changes

  The owner's/holder's name has been changed to Sanofi.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the ATMOSS Australian Trade Mark On-line Search System.

Next and Previous Trademarks/Applications

1042348-ISIDUO

1042346-ISTHROMB